Non-Nicotine Agents for Smoking Cessation
The primary objective of this study is to determine which is the better approach to smoking cessation in veterans: bupropion combined with transdermal nicotine or high dose nicotine replacement therapy (NRT) using transdermal nicotine combined with nicotine inhaler.
Tobacco Use Disorder
Drug: bupropion and transdermal patch
Drug: transdermal patch and nicotine inhaler
|Study Design:||Allocation: Randomized
Masking: Open Label
Primary Purpose: Treatment
|Official Title:||Non-Nicotine Agents for Smoking Cessation|
|Study Start Date:||October 2003|
|Estimated Study Completion Date:||September 2005|
This study is a two-arm open-label, randomized controlled trial of bupropion combined with transdermal nicotine versus high dose NRT (transdermal nicotine and nicotine inhaler) with all subjects receiving a behavioral counseling program for smoking cessation.
Please refer to this study by its ClinicalTrials.gov identifier: NCT00108537
|United States, Colorado|
|Denver VA Medical Center|
|Denver, Colorado, United States, 80220|